Bio-Path Holdings (NASDAQ: BPTH) reported Q4 EPS of ($1.91), $1.44 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.